Platelet-released supernatant induces osteoblastic differentiation of human mesenchymal stem cells: Potential role of BMP-2

European Cells and Materials

Volumn 20, Issue , 2010, Pages 403-414

  Verrier, S ^a   Meury, T R ^a   Kupcsik, L ^a   Heini, P ^b   Stoll, T ^c   Alini, Mauro ^a  

^a AO RESEARCH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c Synthes   (Switzerland)

Author keywords

Differentiation; Growth factors; Mesenchymal stem cells; Osteoblast; Platelets

Indexed keywords

BIOLOGICAL FACTOR; BMP2 PROTEIN, HUMAN; BONE MORPHOGENETIC PROTEIN 2; CALCIUM;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLOOD; CELL CULTURE; CELL DIFFERENTIATION; CELL FRACTIONATION; CYTOLOGY; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKER; HUMAN; MALE; MESENCHYMAL STEM CELL; METABOLISM; MIDDLE AGED; OSTEOBLAST; PHYSIOLOGY; THROMBOCYTE;

ADULT; AGED; BIOLOGICAL FACTORS; BLOOD PLATELETS; BONE MORPHOGENETIC PROTEIN 2; CALCIUM; CELL DIFFERENTIATION; CELLS, CULTURED; FEMALE; GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; MALE; MESENCHYMAL STEM CELLS; MIDDLE AGED; OSTEOBLASTS; SUBCELLULAR FRACTIONS;

EID: 79953108520     PISSN: 14732262     EISSN: None     Source Type: Journal    
DOI: 10.22203/eCM.v020a33     Document Type: Article

References (55)

1. Abe E., Yamamoto M, Taguchi Y, Lecka-Czernik B, O'Brien CA, Economides AN, Stahl N, Jilka RL, Manolagas S. C (2000) Essential requirement of BMPs-2/ 4 for both osteoblast and osteoclast formation in murine bone marrow cultures from adult mice: antagonism by noggin. J Bone Miner Res 15: 663-673.
2. Alini M., Carey D, Hirata S, Grynpas MD, Pidoux I, Poole A. R (1994) Cellular and matrix changes before and at the time of calcification in the growth plate studied in vitro: arrest of type X collagen synthesis and net loss of collagen when calcification is initiated. J Bone Miner Res 9: 1077-1087.
3. Anderson J. M (1999) The cellular cascades of wound healing. In: Bone Engineering (Davies JE, ed). em squared inc, Toronto, Ont, Canada, pp 81-93.
4. Anitua E., Andia I, Ardanza B, Nurden P, Nurden AT (2004) Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost 91: 4-15.
5. Arpornmaeklong P., Kochel M, Depprich R, Kubler NR, Wurzler K. K (2004) Influence of platelet-rich plasma (PRP) on osteogenic differentiation of rat bone marrow stromal cells. An in vitro study. Int J Oral Maxillofac Surg 33: 60-70.
6. Bianchi G., Banfi A, Mastrogiacomo M, Notaro R, Luzzatto L., Cancedda R, Quarto R (2003) Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. Exp Cell Res 287: 98-105.
7. Bolano L., Kopta JA (1991) The immunology of bone and cartilage transplantation. Orthopedics 14: 987-996.
8. Brodke D., Pedrozo HA, Kapur TA, Attawia M, Kraus KH, Holy CE, Kadiyala S, Bruder SP (2006) Bone grafts prepared with selective cell retention technology heal canine segmental defects as effectively as autograft. J Orthop Res 24: 857-866.
9. Chen D., Harris MA, Rossini G, Dunstan CR, Dallas SL, Feng JQ, Mundy GR, Harris SE (1997) Bone morphogenetic protein 2 (BMP-2) enhances BMP-3, BMP-4, and bone cell differentiation marker gene expression during the induction of mineralized bone matrix formation in cultures of fetal rat calvarial osteoblasts. Calcif Tissue Int 60: 283-290.
10. Chen T. L, Hauschka PV, Cabrales S, Feldman D (1986) The effects of 1,25-dihydroxyvitamin D3 and dexamethasone on rat osteoblast-like primary cell cultures: receptor occupancy and functional expression patterns for three different bioresponses. Endocrinology 118: 250-259.
11. Cheng S. L, Yang JW, Rifas L, Zhang SF, Avioli LV (1994) Differentiation of human bone marrow osteogenic stromal cells in vitro: induction of the osteoblast phenotype by dexamethasone. Endocrinology 134: 277-286.
12. Cheng S. L, Zhang SF, Avioli LV (1996) Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells. J Cell Biochem 61: 182-193.
13. Choi B. H, Zhu SJ, Kim BY, Huh JY, Lee SH, Jung JH (2005) Effect of platelet-rich plasma (PRP) concentration on the viability and proliferation of alveolar bone cells: an in vitro study. Int J Oral Maxillofac Surg 34: 420-424.
14. Cooper M. S (2004) Sensitivity of bone to glucocorticoids. Clin Sci (Lond) 107: 111-123.
15. Cooper M. S, Hewison M, Stewart PM (1999) Glucocorticoid activity, inactivity and the osteoblast. J Endocrinol 163: 159-164.
16. Diefenderfer D. L, Osyczka AM, Garino JP, Leboy PS (2003) Regulation of BMP-induced transcription in cultured human bone marrow stromal cells. J Bone Joint Surg Am 85-A Suppl 3: 19-28.
17. Graziani F., Ivanovski S, Cei S, Ducci F, Tonetti M, Gabriele M. (2006) The in vitro effect of different PRP concentrations on osteoblasts and fibroblasts. Clin Oral Implants Res 17: 212-219.
18. Gruber R., Karreth F, Fischer MB, Watzek G (2002a) Platelet-released supernatants stimulate formation of osteoclast-like cells through a prostaglandin/ RANKLdependent mechanism. Bone 30: 726-732.
19. Gruber R., Varga F, Fischer MB, Watzek G (2002b) Platelets stimulate proliferation of bone cells: involvement of platelet-derived growth factor, microparticles and membranes. Clin Oral Implants Res 13: 529-535.
20. Gruber R., Karreth F, Frommlet F, Fischer MB, Watzek G (2003) Platelets are mitogenic for periosteum-derived cells. J Orthop Res 21: 941-948.
21. Igarashi M., Kamiya N, Hasegawa M, Kasuya T, Takahashi T., Takagi M (2004) Inductive effects of dexamethasone on the gene expression of Cbfa1, Osterix and bone matrix proteins during differentiation of cultured primary rat osteoblasts. J Mol Histol 35: 3-10.
22. Jimenez M. J, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C (1999) Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 19: 4431-4442.
23. Jorgensen N. R, Henriksen Z, Sorensen OH, Civitelli R (2004) Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts. Steroids 69: 219-226.
24. Kilian O., Alt V, Heiss C, Jonuleit T, Dingeldein E, Flesch I., Fidorra U, Wenisch S, Schnettler R (2005) New blood vessel formation and expression of VEGF receptors after implantation of platelet growth factor-enriched biodegradable nanocrystalline hydroxyapatite. Growth Factors 23: 125-133.
25. Kim I. S, Song YM, Cho TH, Park YD, Lee KB, Noh I, Weber F., Hwang SJ (2008) In vitro response of primary human bone marrow stromal cells to recombinant human bone morphogenic protein-2 in the early and late stages of osteoblast differentiation. Dev Growth Differ 50: 553-564.
26. Kitoh H., Kitakoji T, Tsuchiya H, Mitsuyama H, Nakamura H., Katoh M, Ishiguro N (2004) Transplantation of marrow-derived mesenchymal stem cells and plateletrich plasma during distraction osteogenesis-a preliminary result of three cases. Bone 35: 892-898.
27. Kiuru J., Viinikka L, Myllyla G, Pesonen K, Perheentupa J (1991) Cytoskeleton-dependent release of human platelet epidermal growth factor. Life Sci 49: 1997-2003.
28. Komori T., Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimoto T (1997) Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89: 755-764.
29. Lee K. S, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney J. M, Kim EG, Choi JY, Ryoo HM, Bae SC (2000) Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20: 8783-8792.
30. Lin S. S, Landesberg R, Chin HS, Lin J, Eisig SB, Lu HH (2006) Controlled release of PRP-derived growth factors promotes osteogenic differentiation of human mesenchymal stem cells. Conf Proc IEEE Eng Med Biol Soc 1: 4358-4361.
31. Lowery G. L, Kulkarni S, Pennisi AE (1999) Use of autologous growth factors in lumbar spinal fusion. Bone 25: 47S-50S.
32. Lucarelli E., Beccheroni A, Donati D, Sangiorgi L, Cenacchi A., Del Vento AM, Meotti C, Bertoja AZ, Giardino R, Fornasari PM, Mercuri M, Picci P (2003) Plateletderived growth factors enhance proliferation of human stromal stem cells. Biomaterials 24: 3095-3100.
33. Lucarelli E., Fini M, Beccheroni A, Giavaresi G, Di Bella C., Aldini NN, Guzzardella G, Martini L, Cenacchi A, Di Maggio N, Sangiorgi L, Fornasari PM, Mercuri M, Giardino R., Donati D (2005) Stromal stem cells and platelet-rich plasma improve bone allograft integration. Clin Orthop Relat Res (435): 62-68.
34. Martin I., Muraglia A, Campanile G, Cancedda R, Quarto R. (1997) Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. Endocrinology 138: 4456-4462.
35. Marx R. E, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss J. E, Georgeff KR (1998) Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 85: 638-646.
36. Mbalaviele G., Sheikh S, Stains JP, Salazar VS, Cheng SL, Chen D, Civitelli R (2005) Beta-catenin and BMP-2 synergize to promote osteoblast differentiation and new bone formation. J Cell Biochem 94: 403-418.
37. McCulloch CA, Tenenbaum HC (1986) Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture. Anat Rec 215: 397-402.
38. Meury T., Verrier S, Alini M (2006) Human endothelial cells inhibit BMSC differentiation into mature osteoblasts in vitro by interfering with osterix expression. J Cell Biochem 98: 992-1006.
39. Miller M. A, Ivkovic A, Porter R, Harris MB, Estok DM, Smith R. M, Evans CH, Vrahas MS (2010) Autologous bone grafting on steroids: preliminary clinical results. A novel treatment for nonunions and segmental bone defects. Int Orthop, in press.
40. Mooren R. E, Merkx MA, Bronkhorst EM, Jansen JA, Stoelinga P. J (2007) The effect of platelet-rich plasma on early and late bone healing: an experimental study in goats. Int J Oral Maxillofac Surg 36: 626-631.
41. Nakashima K., Zhou X, Kunkel G, Zhang Z, Deng JM, Behringer R. R, de Crombrugghe B (2002) The novel zinc finger-containing transcription factor osterix is required for osteoblast differentiation and bone formation. Cell 108: 17-29.
42. Osyczka A. M, Diefenderfer DL, Bhargave G, Leboy PS (2004) Different effects of BMP-2 on marrow stromal cells from human and rat bone. Cells Tissues Organs 176: 109-119.
43. Osyczka A. M, Leboy PS (2005) Bone morphogenetic protein regulation of early osteoblast genes in human marrow stromal cells is mediated by extracellular signalregulated kinase and phosphatidylinositol 3-kinase signaling. Endocrinology 146: 3428-3437.
44. Rawadi G., Vayssiere B, Dunn F, Baron R, Roman-Roman S. (2003) BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res 18: 1842-1853.
45. Roldan J. C, Jepsen S, Miller J, Freitag S, Rueger DC, Acil Y., Terheyden H (2004) Bone formation in the presence of platelet-rich plasma vs. bone morphogenetic protein-7. Bone 34: 80-90.
46. Tomoyasu A., Higashio K, Kanomata K, Goto M, Kodaira K., Serizawa H, Suda T, Nakamura A, Nojima J, Fukuda T., Katagiri T (2007) Platelet-rich plasma stimulates osteoblastic differentiation in the presence of BMPs. Biochem Biophys Res Commun 361: 62-67.
47. Uggeri J., Belletti S, Guizzardi S, Poli T, Cantarelli S, Scandroglio R., Gatti R (2007) Dose-dependent effects of platelet gel releasate on activities of human osteoblasts. J Periodontol 78: 1985-1991.
48. Weibrich G., Kleis WK, Hafner G, Hitzler WE (2002) Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 30: 97-102.
49. Whitman D. H, Berry RL, Green DM (1997) Platelet gel: an autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 55: 1294-1299.
50. Wozney J. M, Rosen V (1998) Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. Clin Orthop Relat Res (346): 26-37.
51. Yamada Y., Ueda M, Hibi H, Nagasaka T (2004a) Translational research for injectable tissue-engineered bone regeneration using mesenchymal stem cells and plateletrich plasma: from basic research to clinical case study. Cell Transplant 13: 343-355.
52. Yamada Y., Ueda M, Naiki T, Takahashi M, Hata K, Nagasaka T. (2004b) Autogenous injectable bone for regeneration with mesenchymal stem cells and plateletrich plasma: tissue-engineered bone regeneration. Tissue Eng 10: 955-964.
53. Yamaguchi A., Komori T, Suda T (2000) Regulation of osteoblast differentiation mediated by bone morphogenetic proteins, hedgehogs, and Cbfa1. Endocr Rev 21: 393-411.
54. Zhou Y. S, Liu YS, Tan JG (2006) Is 1, 25-dihydroxyvitamin D3 an ideal substitute for dexamethasone for inducing osteogenic differentiation of human adipose tissue-derived stromal cells in vitro? Chin Med J. (Engl) 119: 1278-1286.
55. Zimmerman L. B, Jesus-Escobar JM, Harland RM (1996) The Spemann organizer signal noggin binds and inactivates bone morphogenetic protein 4. Cell 86: 599-606.